[Clinical studies of a new antirheumatic-analgesic drug combination].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D000814:Aniline Compounds / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004338:Drug Combinations; D004361:Drug Tolerance; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy*; D010113:Oxyphenbutazone / Q000627:therapeutic use; D011422:Propionates / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use; D012585:Sciatica / Q000188:drug therapy; D013122:Spinal Diseases / Q000188:drug therapy*
D000700:Analgesics; D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D011422:Propionates; D011437:Propylamines; D010113:Oxyphenbutazone
Osservazioni cliniche su di una nuova associazione antireumatica-analgesica.